Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.

13.48
EUR
-0.26
(-1.89%)
0.12EPS
130.48P/E
1.73BMarket Cap
Mar 03Next Earn

Sarepta Therapeutics, Inc. Documents

Q3 FY2025 · Presentation

November 3, 2025 · 42 pages

Read Sarepta Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q3 FY2025 documents